In uveal melanoma cells in particular, treatment with a MEK inhibitor results in a potent downregulation of both EGR1 and its transcriptional targets [75], while forced reduction in EGR1 expression was reported to attenuate growth and impart sensitivity to MEK inhibition [76]. The gene discussed is EGR1; the disease is uveal melanoma.